GAREM2

Chr 2

GRB2 associated regulator of MAPK1 subtype 2

Also known as: FAM59B, GAREML

Predicted to act upstream of or within several processes, including cognition; neuron projection extension; and social behavior. [provided by Alliance of Genome Resources, Jul 2025]

OMIMResearchGenerating clinical summary…

Clinical highlights

Interpreting a novel variant
This gene is strongly intolerant of loss-of-function variation in the population, so LoF variants warrant close attention. No curated mechanism annotation is available — see the mechanism card for the computational prediction and its caveats.Based on population constraint only.
0
Active trials
1
Pubs (1 yr)
P/LP submissions
P/LP missense
0.49
LOEUF
GOF
Mechanism· predicted

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Moderate LoF intolerance
LoF Constraint?
0.49LOEUF
pLI 0.439
Z-score 3.13
OE 0.22 (0.100.49)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint?
1.73Z-score
OE missense 0.74 (0.670.82)
264 obs / 355.8 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.22 (0.100.49)
00.351.4
Missense OE?0.74 (0.670.82)
00.61.4
Synonymous OE?0.92
01.21.6
LoF obs/exp: 4 / 18.5Missense obs/exp: 264 / 355.8Syn Z: 0.77

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

GAREM2 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →